Baidu
map

国外各大医药企业中英文名字双语对照

2010-07-03 MedSci原创 MedSci原创

国外各大医药企业中英文名字对照 北美 生产商英文名            生产商中文名 1 A&Z Pharmaceutical Inc   美国安士制药有限公司 2 Abbott Laboratories Ltd    美国雅培制药有限公司 3 Alcon Ophthalmology Products Co Ltd   爱尔康眼科产品有限公司 4 Allergan Pharmaceu

国外各大医药企业中英文名字对照

北美
生产商英文名            生产商中文名
1 A&Z Pharmaceutical Inc   美国安士制药有限公司
2 Abbott Laboratories Ltd    美国雅培制药有限公司
3 Alcon Ophthalmology Products Co Ltd   爱尔康眼科产品有限公司
4 Allergan Pharmaceutical Co Ltd   美国眼力健制药有限公司
5 AMT Labs INC, USA    美国矿维公司
6 Apotex Inc Canada   加拿大奥贝泰克制药有限公司
7 Bristol Myers Squibb   美国百时美施贵宝公司
8 Chiron S.p.A.   美国凯龙疫苗公司
9 Eli Lilly Inc   美国礼来公司
10 Ivax Pharmaceutical Co Ltd   美国安维世制药有限公司
11 Merck   美国默克公司
12 Mission Pharmacal   美国美信药业公司
13 Pfizer Pharmaceuticals Ltd   美国辉瑞制药有限公司
14 Schering-Plough Ltd   美国先灵葆雅公司
15 SciClone Pharmaceuticals   美国赛生药品股份国际有限公司
16 Dermik Pharmaceutical Co Ltd 美国德美克制药有限公司(安万特公司的子公司)
17 Johnson & Johnson Pharmaceuticals Ltd   美国强生制药有限公司
18 Bristol-Myers Squibb   美国百时美施贵宝公司
19 Wyeth Ltd   美国惠氏公司
20 Parke-Davis   美国派德药厂
  
欧洲
生产商英文名          生产商中文名

1 Almirall Prodesfarma   西班牙艾美罗医用药物有限公司
2 AstraZeneca Pharmaceutical Co Ltd   阿斯利康制药有限公司
3 Aventis Behring   安万特贝林
4 B Braun Medical (H.K.) Ltd   德国贝朗医疗有限公司
5 Bayer   拜耳医药保健有限公司
6 Beaufour Ipsen Pharmaceutical Co Ltd   博福-益普生制药有限公司
7 Berlin-Chemie AG (Menarini Group)   柏林化学股份公司(美纳里尼集团)
8 Biomedica Foscama Chemical Pharmaceutical Industry  意大利福斯卡玛生化制药公司
9 Mundipharma Pharmaceutical Co Ltd   英国萌蒂制药有限公司
10 Boehringer Ingelheim   德国勃林格殷格翰制药公司
11 Chiesi Farmaceutici SpA   意大利凯西制药公司
12 Codal Synto Ltd 塞浦路斯高特制药有限公司
13 Ferring Pharmaceuticals Ltd   荷兰辉凌制药有限公司
14 Laboratoires Fournier  法国利博福尼制药有限公司
15 Fresenius Kabi Pharmaceutical Co Ltd   德国费森尤斯卡比医药有限公司
16 Laboratoires Galderma S.A.   法国高德美制药公司
17 GlaxoSmithKline   葛兰素史克公司
18 Grunenthal Co Ltd   德国格兰泰
19 Leo Pharmaceutical Products   丹麦利奥制药有限公司
20 Organon Pharmaceutical Co Ltd   荷兰欧加农制药有限公司
21 Norgine Ltd   英国诺金有限公司
22 Novartis Pharma Ltd   瑞士诺华制药有限公司
23 Novo Nordisk Biotechnology Co Ltd   丹麦诺和诺德生物技术有限公司
24 Nutricia   荷兰纽迪希亚制药有限公司
25 OM Pharmaceuticals   瑞士欧姆制药有限公司
26 Pharmacia 法玛西亚公司
27 Pharmaton SA   瑞士富马有限公司(勃林格殷格翰集团)
28 Laboratories Pierre Fabre   法国皮尔·法伯药物研制公司
29 Pliva Pharmaceutical Industry Incorporated  克罗地亚普利瓦医药工业股份有限公司
30 ratiopharm International GmbH/Merckle GmbH   德国通益国际制药有限责任公司/德国麦克乐药厂
31 Recordati   意大利利康化工及制药有限公司
32 Sanofi-Synthelabo  法国赛诺菲圣德拉堡
33 Schaper & Brummer GmbH & Co KG   德国夏菩天然药物制药公司
34 Schering Pharmaceutical Ltd   德国先灵公司
35 Schwarz Pharma Co Ltd   德国许瓦兹制药有限公司
36 Servier International   法国施维雅国际公司
37 Ethypharm Pharmaceutical Co Ltd   法国爱的发制药有限公司
38 Roche Pharmaceutical Ltd   瑞士罗氏制药有限公司
39 Teva Pharmaceutical Industries Ltd   以色列梯瓦制药工业有限公司
40 Laboratoires Besins International   法国法杏大药厂
41 Laboratoires Biocodex   法国百科达药厂
42 Bruschettini S.r.I.   意大利贝斯迪大药厂
43 Byk Gulden   德国百克顿药厂
44 Dr. Falk Pharma GMBH   德国福克大药厂
45 Gedeon Richter Ltd   匈牙利吉瑞大药厂
46 Laboratoires Jacques Logeais   法国洛斯大药厂
47 Laphal Laboratories   法国纳化制药厂
48 Lek Pharmaceutical Co   斯洛文尼亚力奇制药和化学工厂
49 Laboratoires Leurquin Mediolanum SA   法国乐康美的澜制药厂
50 Italy Lisapharma S.p.A   意大利利沙大药厂
51 Lundbeck   丹麦灵北药厂
52 Heinrich Mack Nachf. GmbH & Co. KG   德国马赫大药厂
53 Madaus AG   德国马博士大药厂
54 Medochemie Ltd   塞浦路斯麦道甘美大药厂
55 Mepha   瑞士美化药厂
56 Pohl-Boskamp GmbH & Co   德国保时佳大药厂
57 Promedica France-Part of Chiesi Group 法国康密迪加大药厂(隶属于凯西制药集团)
58 Rotta Research Laboratorium S.p.A.   意大利罗达药厂
59 Sangstat   法国赛达药厂
60 Laboratoires UPSA France   法国玉莎大药厂
  
亚洲及澳洲
生产商英文名            生产商中文名

  
1 Atlantic Laboratories Corp Ltd   泰国大西洋制药厂有限公司
2 Otsuka Pharmaceutical Co Ltd   日本大冢制药有限公司
3 Daiichi Pharmaceutical Co Ltd   日本第一制药株式会社
4 Eisai Co Ltd    日本卫材制药有限公司
5 Faulding Pharmaceuticals Ltd   澳大利亚科鼎制药有限公司
6 Fujisawa    日本藤泽药品工业株式会社
7 Kirin Kunpeng Bio-Pharmaceutical Co Ltd   麒麟鲲鹏生物药业有限公司
8 Ranbaxy Laboratories Ltd    印度兰伯西制药有限公司
9 Sankyo Pharmaceuticals Co Ltd   日本三共株式会社
10 Takeda Pharmaceutical Co Ltd   日本武田药品株式会社
11 Tanabe Seiyaku Co Ltd    日本田边制药有限公司
12 Yamanouchi Pharmaceutical Co Ltd   日本山之内集团公司
13 Asahi Kasei Corporation    日本旭化成株式会社
14 Chugai Pharmaceutical Co Ltd   日本中外制药株式会社
15 Daiichi Pharmaceutical Co Ltd   日本第一制药株式会社
16 Fujisawa Pharmaceutical Co Ltd   日本藤泽药品工业株式会社
17 Hanlim Pharmaceutical Co Ltd   韩国韩林制药株式会社
18 Kyowa Hakko Kogyo Co Ltd   日本协和发酵工业株式会社
19 Meiji Seika Kaisha Ltd    日本明治制果株式会社
20 Miyarisan Pharmaceutical Co Ltd   日本米雅利桑制药株式会社
21 Nippon Kayaku Co Ltd    日本化药株式会社
22 Nippon Shinyaku Co Ltd    日本新药株式会社
23 Nippon Zoki Pharmaceutical Co Ltd   日本脏器制药株式会社
24 Seiko Eiyo Yakuhin Co Ltd   日本生晃荣养药品株式会社
25 Senju Pharmaceutical Ltd   日本千寿制药株式会社
26 Shionogi & Co Ltd   日本盐野义制药株式会社
27 Sumitomo Pharmaceuticals Co Ltd   日本住友制药株式会社
28 Teijin Limited   日本帝人株式会社
29 Toyama Chemical Co Ltd   日本富山化学株式会社

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1935708, encodeId=ca1c1935e08bd, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sat Aug 14 21:28:00 CST 2010, time=2010-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775192, encodeId=3bcb1e75192cb, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sun Oct 10 07:28:00 CST 2010, time=2010-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379613, encodeId=d76713e961354, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408579, encodeId=dc2714085e92b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456002, encodeId=5845145600285, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1935708, encodeId=ca1c1935e08bd, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sat Aug 14 21:28:00 CST 2010, time=2010-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775192, encodeId=3bcb1e75192cb, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sun Oct 10 07:28:00 CST 2010, time=2010-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379613, encodeId=d76713e961354, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408579, encodeId=dc2714085e92b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456002, encodeId=5845145600285, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
    2010-10-10 amyloid
  3. [GetPortalCommentsPageByObjectIdResponse(id=1935708, encodeId=ca1c1935e08bd, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sat Aug 14 21:28:00 CST 2010, time=2010-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775192, encodeId=3bcb1e75192cb, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sun Oct 10 07:28:00 CST 2010, time=2010-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379613, encodeId=d76713e961354, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408579, encodeId=dc2714085e92b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456002, encodeId=5845145600285, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
    2010-07-05 szhvet
  4. [GetPortalCommentsPageByObjectIdResponse(id=1935708, encodeId=ca1c1935e08bd, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sat Aug 14 21:28:00 CST 2010, time=2010-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775192, encodeId=3bcb1e75192cb, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sun Oct 10 07:28:00 CST 2010, time=2010-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379613, encodeId=d76713e961354, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408579, encodeId=dc2714085e92b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456002, encodeId=5845145600285, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
    2010-07-05 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1935708, encodeId=ca1c1935e08bd, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sat Aug 14 21:28:00 CST 2010, time=2010-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775192, encodeId=3bcb1e75192cb, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sun Oct 10 07:28:00 CST 2010, time=2010-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379613, encodeId=d76713e961354, content=<a href='/topic/show?id=398a3e608cd' target=_blank style='color:#2F92EE;'>#双语#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37608, encryptionId=398a3e608cd, topicName=双语)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408579, encodeId=dc2714085e92b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456002, encodeId=5845145600285, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Mon Jul 05 11:28:00 CST 2010, time=2010-07-05, status=1, ipAttribution=)]
    2010-07-05 hyf030
Baidu
map
Baidu
map
Baidu
map